Skip to main content

Phosphoramidite Market Growth Statistics, Prominent Players Strategies, and Growth Forecast to 2032


 

Global Phosphoramidite Market: Industry Overview

The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032. The market growth can be ascribed to the rising demand for oligonucleotides, growing synthetic biology market, increasing partnerships and collaborations, continuous investment for research and development activities by private and public firms, and growing prevalence of several diseases creating an urgent need for novel therapeutic treatments.

Phosphoramidite Market

 

Recent Developments in the Global Phosphoramidite Market

•    In August 2019, the company acquired 75% ordinary capital of the parent company of Toronto Research Chemicals Inc., i.e., Biomed Pharmaceutical Limited.
•    In July 2022, TriLink BioTechnologies expanded its RD leadership team's responsibility for leading the company’s scientific direction and research and development strategy.
•    In May 2022, TriLink BioTechnologies announced a cooperative agreement with the Department of Defense and included funding for TriLink’s expansion in San Diego, California, for nucleic acid production.
•    In November 2021, Biosynth Carbosynth acquired Kexing Biopharmaceutical Co., Ltd.’s raw material manufacturing unit located in Jinan, China, to expand its operations and deliver a wide range of products at a larger production volume and increased capacity. The facility extends to more than 30,000 square meters of area.
•    In November 2021, a leading investment firm, KKR, invested an undisclosed amount and acquired Biosynth Carbosynth from its founders, Armira and Dr. Urs Spitz. However, senior management will retain a significant ownership stake, and KKR will contribute as a strategic partner. KKR plans to encourage and accelerate the company's product portfolio expansion and geographic buildout and widen its capabilities.

Global Phosphoramidite Market Segmentation

Demand - Drivers and Limitations

Following are the demand drivers for the global phosphoramidite market:

•    Increasing Synthetic Nucleotide Applications in Therapeutics
•    Growth in Synthetic Biology

The market is expected to face some limitations due to the following challenges:

•    Challenges in Developing Long Nucleotide Sequences
•    Competition from Emerging DNA Synthesis Technologies


Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, and market penetration.

Some of the prominent names in this market are:

•    Biosynth Carbosynth
•    Bioneer Corporation
•    Lumiprobe Corporation
•    QIAGEN N.V.
•    Danaher Corporation (IDT)
•    TriLink BioTechnologies
•    Creative Biolabs
•    PolyOrg, Inc.
•    Hongene Biotech Corporation
•    ChemGenes
•    BOC Sciences
•    Tokyo Chemical Industry Co., Ltd. (TCI)
•    LGC Science Group Holdings Limited
•    AAT Bioquest, Inc.
•    Thermo Fisher Scientific, Inc.
•    Merck KGaA

 

 

  Key Questions Answered in the Report

  • What are the major market drivers, challenges, and opportunities in the global phosphoramidite market?
  • What are the key development strategies being implemented by the major players to sustain in the competitive market?
  • Which is the dominant phosphoramidite by type developed by the leading and emerging players?
  • What is the impact of COVID-19 on the global phosphoramidite market?
  • How is each segment of the market expected to grow during the forecast period from 2022 to 2032? Following are the segments:
  • Type (DNA phosphoramidites, RNA phosphoramidites, labeled phosphoramidites, and other phosphoramidites)
  • End User (Pharmaceutical and biotechnology companies, diagnostic laboratories, and synthetic biology or research institutes)
  • Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
  • Which companies are anticipated to be highly disruptive in the future, and why?

USP of this report

The following can be seen as some of the USPs of this report:

• Extensive competitive benchmarking of key players offering a holistic view of the global phosphoramidite market landscape 
• Market ranking analysis based on product portfolio, recent developments, and region-level analysis

 

Who should buy this report?

Established companies involved in the development of phosphoramidite-related products such as oligonucleotides and new entrants who want to focus on the phosphoramidite market would be suitable buyers for this report.


BIS Related Studies

Global Oligonucleotide Synthesis Market

Labels:

Comments

Post a Comment

Popular posts from this blog

PP Compound Market for Automotive Industry Open Up New Revenue Opportunities

  The global PP compound market for automotive industry is expected to reach $17,324.8 million by 2031, with a CAGR of 5.6% during the forecast period 2021-2031. The growth in the market is expected to be driven mainly by the need to reduce the weight of vehicles and demand for cheaper products that can be used in automotive parts. Impact of COVID-19 on the Global Polypropylene (PP) Compound Market for Automotive Industry Due to the COVID–19 pandemic, the PP compound market was severely impacted like many other industries. Automotive production in 2020 saw a decline of almost 16% due to the impact of COVID-19. In order to control the spread of the virus, the majority of the countries around the globe imposed stay-at-home orders, which led to the shutting of many manufacturing plants. As the production of vehicles declined, the demand for PP compounds suffered negatively in the year 2020. Market Segmentation Global Polypropylene (PP) Compound Market for Automotive Industry by Applicatio
Post a Comment
Read more

Growing Focus on Patient-Centered Healthcare led to Rise in Urgent Care Apps Market

Urgent care apps are intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring.   Treatment can be offered remotely via text/audio/video calls, or help can be arranged to usher the patient to the nearest hospital. The widespread adoption of smartphones and increased demand for urgent and convenient access to care will be crucial to the market’s growth.  The global urgent care apps market was valued at $973.6 million in 2020 and is anticipated to grow to $10,150.5 million by the end of 2030 at a projected CAGR of 26.32% during the forecast period 2021-2030.   The aforementioned growth is based on the realistic forecast, which is the most likely growth scenario based on current market conditions. This scenario assumes that there will be no visible impact of COVID-19 beyond 2030. The changes in the market during that timeline can build upon the developments of
Post a Comment
Read more

Neoantigen Cancer Vaccine Market Technology Developments and Future Growth

  Looking at the recent oncology care trends, the World Heart Foundation estimates the global cancer treatment expenditure to reach $XX billion in the year 2031.   The increase in overall burden provides an opportunity for several companies to step in and introduce their innovative products in the market. The emergence of the neoantigen cancer vaccine can be considered as an evident example of emerging oncology care that can possibly prevail over the existing hurdles of treatment un-specificity and safety benchmarks. The global neoantigen cancer vaccine industry analysis by BIS Research projects the market to grow at a significant CAGR of 77.73% during the forecast period 2024-2031. The  neoantigen cancer vaccine market  is expected to generate $35.5 million in revenue in 2024, owing to the expected launch of the first neoantigen vaccine, DC vaccine in the market. The neoantigen cancer vaccine market growth has been primarily attributed to major drivers in this market, such as rising p
Post a Comment
Read more